Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
about
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studiesRecent developments in treatment of latent tuberculosis infectionHepatic manifestations of non-steroidal inflammatory bowel disease therapyIsoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosisIsoniazid-related fatal hepatitis.Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysisAdverse events associated with treatment of latent tuberculosis in the general population.Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.A systematic review of economic evaluations of chemoprophylaxis for tuberculosis.Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.Implementation and evaluation of an isoniazid preventive therapy pilot program among HIV-infected patients in Vietnam, 2008-2010Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature.Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?A guide to the management of tuberculosis in patients with chronic liver disease.Current management options for latent tuberculosis: a review.Isoniazid toxicity in a 5-year-old boyBurden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.
P2860
Q24282604-0E54FF49-8C1E-4A89-90AF-3BB774F24EE4Q24630473-4C8C2D47-854B-49D0-BB78-D275428162EEQ26773684-881AFF16-F4F6-4F8C-B233-8DD61EC40698Q28362291-C5D9B71B-E066-48C7-AE39-FB8ED1CDF324Q28379062-4E100CBE-8591-4E5D-88C4-247ABB940C6DQ33247229-624E970E-63DE-47F3-9C11-5F31BD66ED37Q33532816-CDBC3FAA-5135-448B-959C-93E9D44FBA30Q34589993-CA3C2565-69E9-4C78-8896-9B4A1CE3479CQ35336540-43182D63-44F9-483D-9816-B292B52A9E1FQ35503563-DA336922-2A65-431E-A23E-42856912E849Q35567798-606BD65E-9ED6-4C08-9933-AA489D4AA2AAQ36702386-F253BA9F-597E-4956-804A-377FB00987C3Q37239604-4574D018-6703-411F-91DD-82A997A9EFDCQ37296519-BA2C2B99-2055-4739-869E-6AD097F9963EQ37613934-98E41A56-1AF6-41BC-95AF-0BB96C078F79Q38066198-B1EF1A67-BCFD-41F9-9692-D63D4E95E817Q42196885-C1AC177E-2889-4355-8F28-AFCC1FF893CBQ42376840-78CF39C6-626A-4551-AA41-B32CCBD1D70DQ47133419-A999AB33-0B00-4926-9EB2-61572793B867
P2860
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@ast
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@en
type
label
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@ast
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@en
prefLabel
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@ast
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@en
P2860
P1476
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
@en
P2093
S R Salpeter
P2860
P304
P407
P577
1993-11-01T00:00:00Z